MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UP-75-0032804
Medicela Pharmaceuticals Private Limited
Medicela Pharmaceuticals Private Limited - pharma in Thane, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2022
₹8.81 Lakh
Latest filing
Net profit · FY 2022
₹5,400
Net margin 0.6%
EBITDA · FY 2022
₹6,100
EBITDA margin 0.7%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹6 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Medicela Pharmaceuticals Private Limited
Data last updated:
Medicela Pharmaceuticals Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 01 August 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24239PN2020PTC192573. Its GSTIN is 09AANCM6450E1Z9 (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹6 Lakh. It is led by directors Anand Prakash Pandey and Vishnu Deo Tiwari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 101 B Bldg Shiv Tower Singh Nagar, Thane, Maharashtra, India – 400602.
As per the financials filed for FY 2022, the company reported a revenue of ₹8.81 Lakh. For the same year it recorded a net profit of ₹5,400 (net margin 0.6%) and EBITDA of ₹6,100 (EBITDA margin 0.7%).
Medicela Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-75-0032804).
Company details
CIN U24239PN2020PTC192573
Registration Number 192573
Incorporation Date 01 August 2020
ROC Pune
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-UP-75-0032804
Recognitions & Rankings of Medicela Pharmaceuticals
Contact details
Medicela Pharmaceuticals Private Limited's registered office is in Thane, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address101 B Bldg Shiv Tower Singh Nagar, Thane, Maharashtra, India – 400602
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Medicela Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Medicela Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Financials of Medicela Pharmaceuticals Private Limited
FY 2025 filings availableMedicela Pharmaceuticals Private Limited reported revenue of ₹8.81 Lakh for FY 2022.
Revenue · FY 2022
₹8.81 Lakh
Net profit · FY 2022
₹5,400 margin 0.6%
EBITDA · FY 2022
₹6,100 margin 0.7%
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ₹8.81 Lakh | |
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹6,100 | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹5,400 | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 0.7% | |
| Net Profit Margin | 0.6% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Medicela Pharmaceuticals Private Limited, buy the company report.
Board of directors of Medicela Pharmaceuticals Private Limited
Medicela Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anand Prakash Pandey Also directs: Kedarnath Hospitality Services LLP, Av Coreinfra LLP, Kedarnath Educations Private Limited and 2 more | Director | 30 Mar 2024 | 2 Years 7 Months | Current |
| Vishnu Deo Tiwari Also directs: Kedarnath Hospitality Services LLP, Av Coreinfra LLP, Kedarnath Educations Private Limited and 1 more | Director | 30 Mar 2024 | 2 Years 7 Months | Current |
Auditor
Medicela Pharmaceuticals Private Limited is audited by AJAY SONI & CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AJAY SONI & CO | FY 2022 | 015077C |
Shareholding
The shareholding of Medicela Pharmaceuticals Private Limited is on record for FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Medicela Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Medicela Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medicela Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Medicela Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AANCM6450E1Z9 | Uttar Pradesh | Active | 24 Jun 2021 |
To see the full GST registrations and return filing status of Medicela Pharmaceuticals Private Limited, buy the company report.
Recent activity
Medicela Pharmaceuticals Private Limited has 4 board changes on record since 2024: 2 appointments and 2 cessations. The latest: Ankita Tiwari ceased to be Director on 31 Mar 2024.
AGM
Medicela Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Medicela Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune.
Ceased
Ankita Tiwari ceased to be Director.
Ceased
Ankita Tripathi ceased to be Director.
Appointed
Anand Prakash Pandey was appointed as Director.
Appointed
Vishnu Deo Tiwari was appointed as Director.
Incorporation
01 Aug 2020
Medicela Pharmaceuticals Private Limited was registered on 01 Aug 2020 with Roc Pune & aged 6 years 3 months as per MCA records.
Frequently asked questions
Medicela Pharmaceuticals is an active private limited company based in Thane, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 01 August 2020 (6+ years old) and is registered under CIN U24239PN2020PTC192573.
Medicela Pharmaceuticals has 2 current directors:
- Anand Prakash Pandey - Director
- Vishnu Deo Tiwari - Director
The latest financial statements of Medicela Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Medicela Pharmaceuticals is 09AANCM6450E1Z9, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Medicela Pharmaceuticals is U24239PN2020PTC192573. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medicela Pharmaceuticals was incorporated on 01 August 2020, making it 6+ years old. It is registered with the Registrar of Companies, Pune.
Ankita Tiwari ceased to be Director on 31 Mar 2024. Ankita Tripathi ceased to be Director on 31 Mar 2024. Anand Prakash Pandey was appointed as Director on 30 Mar 2024. Medicela Pharmaceuticals has 4 board changes on record in total.
Yes, Medicela Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-75-0032804).
The registered office of Medicela Pharmaceuticals is at 101 B Bldg Shiv Tower Singh Nagar, Thane, Maharashtra, India – 400602.
Medicela Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages